Showing results (41-50 of 90) with videos related to
Sort By:
Pageof 9
Human Molecular Genetics|November 1, 2017
G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brainAn Phu Tran Nguyen, Guillaume Daniel, Pamela Valdés, et al.Neurobiology of Disease|March 4, 2024
Formation of templated inclusions in a forebrain α-synuclein mouse model is independent of LRRK2Dylan J Dues, Yue Ma, An Phu Tran Nguyen, et al.Biorxiv : the Preprint Server for Biology|May 7, 2026
Parkinson's disease-associated LRRK2 risk variant, G2385R, enhances Rab substrate phosphorylation and impairs neuronal integrityAn Phu Tran Nguyen, Roger Moser, Nicole Bryant, et al.Plos One|July 7, 2012
Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonismAgata Podhajska, Alessandra Musso, Alzbeta Trancikova, et al.Neurobiology of Disease|October 15, 2024
Neuropathology in an α-synuclein preformed fibril mouse model occurs independent of the Parkinson's disease-linked lysosomal ATP13A2 proteinCaio M Massari, Dylan J Dues, Alexis Bergsma, et al.Neurobiology of Disease|December 3, 2014
α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9)Guillaume Daniel, Alessandra Musso, Elpida Tsika, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 21, 2011
A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2Julien Dusonchet, Olexiy Kochubey, Klodjan Stafa, et al.Human Molecular Genetics|November 5, 2004
Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stressDarren J Moore, Li Zhang, Juan Troncoso, et al.Human Molecular Genetics|January 6, 2017
Parkin functionally interacts with PGC-1α to preserve mitochondria and protect dopaminergic neuronsLu Zheng, Nathalie Bernard-Marissal, Norman Moullan, et al.Plos One|October 20, 2012
Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutationsAlzbeta Trancikova, Adamantios Mamais, Philip J Webber, et al.Pageof 9